We have been busy preparing our new website to replace this existing site. The new site has a fresher look, is easier to use and offers new levels of accessibility. The information has been simplified and it’s easier to find the help you wantRead More
Hepatitis Australia posts news stories relating to viral hepatitis that may be relevant to people living with hepatitis B or C or the people working within the hepatitis health sector. News stories come from both international and Australian sources. Your comments are welcome but any inappropriate comments, or promotional comments will be removed.
Statement from Hepatitis Australia
The data in Monitoring hepatitis C treatment uptake in Australia – Issue 10 from the Kirby Institute highlights both the progress and deficiencies in hepatitis C treatment uptake. It is great news to see so many people have commenced treatment with most people having been cured, or on their way to being cured. While this is clearly cause for celebration the down side is that the number of people taking up treatment to cure hepatitis C is declining to alarming levels.
Around 74,000 Australians have been cured of hepatitis C through the use of the direct-acting antivirals but elimination by the target date remains in doubt given the significant decline in new patient initiations. The latest report from the Kirby Insitute shows just 16,000 patients were initiated on the treatments in 2018, down from over 32,000 in 2016 and 21,000 in 2017.Read More
Australia also already achieved the WHO’s 2020 mortality target. Some might say that this is good news - but at Hepatitis Australia we don’t agree. Virtually every hepatitis C death occurs because the gold-standard treatment and care available in Australia did not reach the person that needed it in time.Read More
Patient uptake might be languishing in Australia but England has acted and announced a new deal with companies that will involve the pro-active identification of people living with hepatitis C.Read More
Hepatitis Australia has welcomed outcomes from the March PBAC meeting it says are "cognisant" of the need to address the fall in treatment initiations and an election commitment from the Greens.
The committee recommended a number of revisions to the PBS listing of the direct-acting antivirals for hepatitis C with more "significant changes" on the horizon.Read More